Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

RxCell has received a US patent for an iPSC-based cell therapy approach, a method of generating multiple cellular therapy ...

In two new papers, they demonstrate how two TRIM21-based techniques can remove ... because it mostly sits inside of brain ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

BioCentriq has appointed Syed T. Husain as its new chief executive officer (CEO), and as a member of the Board of Directors.

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReadyTM, today announced that ImmunoScape (a Singapore-U.S. based TCR-T therapy company) ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Gene therapy technology offers enormous hope for thousands of people battling sickle cell amenia in part because of the Black Panther Party’s grassroots efforts decades ago.

NanoVation Therapeutics, a Vancouver company co-founded by biotech magnate Pieter Cullis, has struck a partnership with ...

BioCentriq, today announce the appointment of Syed T. Husain as Chief Executive Officer and Board Member ...

Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphomas (NHLs) characterized by the (11,14) ...